Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
This approval is considered a major breakthrough in treating acute pain without the need for opioid medication as reliance on ...
The drug is called Journavx and doctors believe it has no potential for addiction and dependence.
The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...
Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $433 from $430 and keeps a Sector Perform rating on the shares. Vertex’s suzetrigine, branded Journavx, was recently ...
US federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The US Food and Drug ...
The US Food and Drug Administration has approved the first-ever non-opioid pain reliever in more than two decades.According ...
The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid.
A new type of painkiller aimed at treating pain from an injury or surgery has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, also known by its brand name Journavx, ...